| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/18/2006 | WO2006052013A1 Thienopyrrole compounds and utilization thereof as hcv polymerase inhibitor |
| 05/18/2006 | WO2006052007A1 Glycemic controlling agent |
| 05/18/2006 | WO2006051987A1 Novel drug for inhibiting estrogen-dependent diseases, prostaglandin d (pgd)-dependent gynecological diseases, immunological diseases, cancer and angiogenesis |
| 05/18/2006 | WO2006051951A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006051819A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051818A1 Drug for external use and adhesive patch |
| 05/18/2006 | WO2006051757A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 05/18/2006 | WO2006051648A1 Remedy for angiospasm accompanying subarachnoid hemorrhage contianing thrombin receptor antagonist as the active ingredient |
| 05/18/2006 | WO2006051154A1 Treatment of restless legs syndrome |
| 05/18/2006 | WO2006018625A3 Peripheral benzodiazepine receptor independent superoxide generation |
| 05/18/2006 | WO2006000867B1 Compositions for topical treatment |
| 05/18/2006 | WO2006000224A3 Compositions comprising strontium and vitamin d and uses thereof |
| 05/18/2006 | WO2005117895A8 Compositions comprising meloxicam |
| 05/18/2006 | WO2005116653A3 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 05/18/2006 | WO2005107809A8 Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 05/18/2006 | WO2005107717A3 Oral dosage form for the extended release of biguanide and sulfonylurea |
| 05/18/2006 | WO2005097086A3 Use of 5,10-methylene tetrahydrofolate for the treatment of cancer |
| 05/18/2006 | WO2005089804A3 Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
| 05/18/2006 | WO2005079210A3 Methods and compositions for preventing biofilm formations, reducing existing biofilms, and for reducing existing biofilms, and for reducing populations of bacteria |
| 05/18/2006 | WO2005035726A3 Multi-layered polymerizing hydrogels for tissue regeneration |
| 05/18/2006 | US20060107336 Nonbacterial prostatitis model animal |
| 05/18/2006 | US20060106202 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 05/18/2006 | US20060106114 Tertiary amino compounds having opioid receptor affinity |
| 05/18/2006 | US20060106106 Beta-hydroxyphenylalkylamines and their use for treating glaucoma |
| 05/18/2006 | US20060106099 Novel inhibitors of ubiquitin isopeptidases |
| 05/18/2006 | US20060106075 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 05/18/2006 | US20060106065 Methods of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D- glucuitol compounds in combination therapy |
| 05/18/2006 | US20060106057 Stabilization of quinapril using magnesium oxide |
| 05/18/2006 | US20060106052 Method of using sulfonamide substituted imidazoquinolines |
| 05/18/2006 | US20060106044 Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidines |
| 05/18/2006 | US20060106040 Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders |
| 05/18/2006 | US20060106034 Drug efflux pump inhibitor |
| 05/18/2006 | US20060106008 Pharmaceutical use of fused 1,2,4-triazoles |
| 05/18/2006 | US20060105997 Mitotic kinesin inhibitors |
| 05/18/2006 | US20060105994 Treatment of prostate cancer |
| 05/18/2006 | US20060105993 Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 05/18/2006 | US20060105981 Therapeutic agents for treatment of solid tumors comprising an expression-inhibiting substance against Wilms' tumor gene (WT1) |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060105333 Method for diagnosis of intestinal-type gastric tumors |
| 05/18/2006 | US20060105327 Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma |
| 05/18/2006 | US20060105068 Dietary supplement formulations containing Hoodia gordonii |
| 05/18/2006 | US20060105050 Compositions comprising fenofibrate and simvastatin |
| 05/18/2006 | US20060105048 Remedy |
| 05/18/2006 | US20060105046 Polymer conjugates of opioid antagonists |
| 05/18/2006 | US20060105040 Pharmaceutical tablet and process for making thereof |
| 05/18/2006 | US20060104999 Composition for solubilization of paclitaxel and preparation method thereof |
| 05/18/2006 | US20060104998 e.g. 2-Amino-4-(3-bromo-4,5-dimethoxyphenyl)-3-cyano-7-methyl-4H-pyrrolo [2,3-h]chromene; antiproliferative, antitumor, anticarcinogenic agent |
| 05/18/2006 | US20060104984 Methods and compositions for use in treating cancer |
| 05/18/2006 | US20060104913 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 05/18/2006 | US20060104905 Methods of screening agents for activity using teleosts |
| 05/18/2006 | US20060103807 Ophthalmic and ophthalmological use of a complex nutritive base in an aqueous medium |
| 05/18/2006 | DE10349979B4 Medikamentöse gezielte lokale Lipolyse Drug targeted local lipolysis |
| 05/18/2006 | DE10156794B4 Arzneimittel zur Behandlung von Warzen Medicines used to treat warts |
| 05/18/2006 | CA2591474A1 Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy |
| 05/18/2006 | CA2587336A1 Ptpase inhibitors and t-cell activators for treating cancer |
| 05/18/2006 | CA2586950A1 Methods and compositions using immunomodulatory compounds for treatment and management of parasitic diseases |
| 05/18/2006 | CA2584806A1 Treatment of obesity and related disorders |
| 05/18/2006 | CA2584225A1 Compositions for treating flushing and lipid-associated disorders comprising niacin receptor partial agonists |
| 05/18/2006 | CA2583187A1 Method for treating hiv infection through co-administration of tipranavir and etravirine |
| 05/17/2006 | EP1657256A2 Compositions and methods for the treatment of tumor |
| 05/17/2006 | EP1657255A1 Novel protein and method for producing the protein |
| 05/17/2006 | EP1657247A1 Steroidal compounds for inhibiting steroid sulphotase |
| 05/17/2006 | EP1656939A1 Use of melatonin in the manufacture of a medicament for treating cancer |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656159A2 Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
| 05/17/2006 | EP1656128A1 Treatment for acne vulgaris and method of use |
| 05/17/2006 | EP1656122A1 Medicament preparations for transdermal application containing active ingredient combinations for treating parkinson's disease |
| 05/17/2006 | EP1656094A2 Methods of improving the safety of zonisamide therapy |
| 05/17/2006 | EP1656025A2 A stable liquid probiotic composition, preparation and applications thereof |
| 05/17/2006 | EP1413174A4 Mounting arrangement for auxiliary burner or lance |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1330293B1 Controlled release composition comprising lactic acid polymer, and method of producing the same |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1307202B1 Method for the treatment of overactive bladder |
| 05/17/2006 | EP1280555B1 Pharmaceutical composition comprising furosemide and conivaptan for the treatment of congestive heart failure |
| 05/17/2006 | EP1274711B1 New aza-indolyl derivatives |
| 05/17/2006 | EP1272220B1 Formulation for the prevention of cardiovascular disease |
| 05/17/2006 | EP1231983B1 Combination of dhea and calcitonin for the treatment of subnormal bone mineral density |
| 05/17/2006 | EP1214598B1 Screening for inhibitors of "paired helical filaments" |
| 05/17/2006 | EP1135411B1 Methods and compositions for treating disorders involving excitotoxicity |
| 05/17/2006 | EP1115372B1 Fast dissolving orally consumable films |
| 05/17/2006 | EP1007101B1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774265A Drug for nerve regeneration |
| 05/17/2006 | CN1774253A Treatment of refractory tumors using epothilone derivatives |
| 05/17/2006 | CN1774251A Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists |
| 05/17/2006 | CN1774242A Methods for preparation and use of 1alpha,24(s)-dihydroxyvitamin d2 |
| 05/17/2006 | CN1774179A Multi-vitamin and mineral supplement for pregnant women |
| 05/17/2006 | CN1771973A Composite medicine containing nonsteroidal anti-inflammatory analgetic and its prepn |
| 05/17/2006 | CN1771943A Novel method of treatment |
| 05/17/2006 | CN1771929A Treatment of pcp addiction and pcp addiction-related behavior |
| 05/17/2006 | CN1256154C Method for culturing germ interstitial cell |
| 05/16/2006 | US7045636 MCH antagonists for the treatment of obesity |
| 05/16/2006 | US7045550 In situ administering; side effect reduction of cancer therapy |